GSK-114260

Study Sponsor: GSK

Study Title

Immunogenicity and safety of GlaxoSmithKline Biologicals’ DTPa-IPV/Hib (Infanrix™-IPV+Hib) vaccine in healthy Korean infants

Medicine or Vaccine (generic name)

Combined Diphtheria, Tetanus, Acellular Pertussis, Inactivated Polio, Haemophilus influenzae Type b Conjugate Vaccine

Sponsor Identification Number

114260

Trial Registry Identification Number(#'s)

NCT01309646 2012-004137-16

Medical Condition

acellular pertussis; Diphtheria; Haemophilus influenzae type b; Poliomyelitis; Tetanus

Phase

Phase 3

Link to GSK Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

December 2018